Prestige Consumer Healthcare Inc. (PBH)

NYSE: PBH · IEX Real-Time Price · USD
55.29
-2.39 (-4.14%)
May 18, 2022 4:00 PM EDT - Market closed
Market Cap2.78B
Revenue (ttm)1.09B
Net Income (ttm)205.38M
Shares Out50.28M
EPS (ttm)3.72
PE Ratio14.86
Forward PE13.50
Dividendn/a
Ex-Dividend Daten/a
Volume319,462
Open57.22
Previous Close57.68
Day's Range54.94 - 57.53
52-Week Range49.09 - 63.83
Beta0.65
AnalystsBuy
Price Target67.73 (+22.5%)
Earnings DateMay 5, 2022

About PBH

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye allergies/redness relief, Compound W wart removals, Debrox ear wax removals, DenTek for PEG ora...

IndustryPharmaceuticals
IPO DateFeb 10, 2005
Employees505
Stock ExchangeNYSE
Ticker SymbolPBH
Full Company Profile

Financial Performance

In 2021, PBH's revenue was $1.09 billion, an increase of 15.21% compared to the previous year's $943.37 million. Earnings were $205.38 million, an increase of 24.71%.

Financial Statements

Analyst Forecast

According to 11 analysts, the average rating for PBH stock is "Buy." The 12-month stock price forecast is 67.73, which is an increase of 22.50% from the latest price.

Price Target
$67.73
(22.50% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Prestige Consumer (PBH) Stock Up on Q4 Earnings & Revenue Beat

Prestige Consumer's (PBH) fourth-quarter results benefit from strong consumer demand and strength in certain categories that were earlier affected by the pandemic.

1 week ago - Zacks Investment Research

Prestige Brands (PBH) Tops Q4 Earnings and Revenue Estimates

Prestige Brands (PBH) delivered earnings and revenue surprises of 2.25% and 3.38%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

1 week ago - Zacks Investment Research

Prestige Consumer Healthcare Inc. Reports Record Results for Fiscal 2022

TARRYTOWN, N.Y., May 05, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its fourth quarter and fiscal year ended March 31, 2022.

1 week ago - GlobeNewsWire

What's in Store for Prestige Consumer (PBH) in Q4 Earnings?

Prestige Consumer's (PBH) fourth-quarter results are likely to reflect high demand for certain categories and gains from buyouts, while high costs are a concern.

2 weeks ago - Zacks Investment Research

Prestige Brands Getting Closer To Key Technical Measure

Prestige Brands shows improving price performance, earning an upgrade to its IBD Relative Strength Rating The post Prestige Brands Getting Closer To Key Technical Measure appeared first on Investor's Bu...

4 weeks ago - Investors Business Daily

Prestige Consumer Healthcare Inc. to Release Fiscal 2022 Fourth Quarter and Year-End Earnings Results

TARRYTOWN, N.Y., April 14, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2022 fourth quarter and year-end earnings release on Thursd...

1 month ago - GlobeNewsWire

Prestige Consumer (PBH) Hurt by High Costs, Solid Demand Aids

Prestige Consumer Healthcare (PBH) is battling elevated cost and supply-chain challenges, while domestic consumer healthcare demand for certain categories has been aiding the company.

1 month ago - Zacks Investment Research

Prestige Consumer (PBH) Well Poised on Solid Brand, E-Commerce

Prestige Consumer Healthcare (PBH) has been gaining on its robust brand portfolio. Prudent acquisitions and e-commerce strength are working well for the company.

2 months ago - Zacks Investment Research

What Makes Prestige Brands (PBH) a New Buy Stock

Prestige Brands (PBH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

3 months ago - Zacks Investment Research

Prestige Consumer (PBH) Rises on Q3 Earnings Beat, Raised View

Prestige Consumer's (PBH) third-quarter results benefit from strong consumer demand and the strength in certain categories that were earlier affected by the pandemic. Management ups fiscal 2022 view.

3 months ago - Zacks Investment Research

Prestige Brands (PBH) Beats Q3 Earnings and Revenue Estimates

Prestige Brands (PBH) delivered earnings and revenue surprises of 11.24% and 5.57%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

Prestige Consumer Healthcare Inc. Reports Fiscal 2022 Third Quarter Results

TARRYTOWN, N.Y., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its third quarter ended December 31, 2021.

3 months ago - GlobeNewsWire

Factors to Know Ahead of Prestige Consumer (PBH) Q3 Earnings

Gains from brand-building strategies, e-commerce operations and buyouts might contribute to Prestige Consumer's (PBH) third-quarter fiscal 2022 results.

3 months ago - Zacks Investment Research

Prestige Brands (PBH) Reports Next Week: Wall Street Expects Earnings Growth

Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 months ago - Zacks Investment Research

Prestige Consumer Healthcare Inc. to Release Fiscal 2022 Third Quarter Earnings Results

TARRYTOWN, N.Y., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2022 third quarter earnings release on Thursday, February 3,...

4 months ago - GlobeNewsWire

Should Value Investors Consider Prestige (PBH) Stock Now?

Let's see if Prestige (PBH) stock is a good choice for value-oriented investors right now from multiple angles.

4 months ago - Zacks Investment Research

Prestige Consumer (PBH) Tops Q2 Earnings & Revenue Estimates

Prestige Consumer's (PBH) Q2 results reflect gains from solid demand and continued recovery in certain categories. Encouragingly, it raises the fiscal 2022 guidance.

6 months ago - Zacks Investment Research

Prestige Brands (PBH) Beats Q2 Earnings and Revenue Estimates

Prestige Brands (PBH) delivered earnings and revenue surprises of 3.03% and 5.71%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

Prestige Consumer Healthcare Inc. Reports Fiscal 2022 Second Quarter Results

TARRYTOWN, N.Y., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its second quarter ended September 30, 2021.

6 months ago - GlobeNewsWire

Prestige Consumer (PBH) to Post Q2 Earnings: Things to Note

Prestige Consumer's (PBH) performance in the fiscal second quarter is likely to have gained from strong brand offerings, especially in healthcare, as well as growing e-commerce sales.

6 months ago - Zacks Investment Research

Prestige Brands (PBH) Earnings Expected to Grow: Should You Buy?

Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

6 months ago - Zacks Investment Research

Prestige Consumer Healthcare Inc. to Release Fiscal 2022 Second Quarter Earnings Results

TARRYTOWN, N.Y., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2022 second quarter earnings release on Thursday, November 4...

7 months ago - GlobeNewsWire

LCUT vs. PBH: Which Stock Is the Better Value Option?

LCUT vs. PBH: Which Stock Is the Better Value Option?

Other symbols:LCUT
7 months ago - Zacks Investment Research

Prestige Consumer Healthcare (PBH) Sees Hammer Chart Pattern: Time to Buy?

Prestige Consumer Healthcare (PBH) has been struggling lately, but the selling pressure may be coming to an end soon.

8 months ago - Zacks Investment Research

Prestige Consumer (PBH) Surges More Than 65% YTD: Here's Why

Prestige Consumer (PBH) is consistently making multi-year e-commerce investments, which are yielding well. The company is focusing on the areas with significant prospects, such as healthcare.

8 months ago - Zacks Investment Research